Vext Science (TSE:VEXT) has released an update.
Vext Science, Inc. reported its financial results for Q4 and the full year of 2023, showcasing a revenue of $34.8 million and an EBITDA of $16.6 million, with significant growth anticipated from the launch of an adult-use program in Ohio. The company is well-positioned with a vertically-integrated operation in Ohio, expecting to capture a considerable market share as Ohio’s cannabis market is projected to reach $4 billion by 2028. Vext’s strategic initiatives in Arizona and expansion in Ohio are set to enhance long-term profitability and cash flow.
For further insights into TSE:VEXT stock, check out TipRanks’ Stock Analysis page.
